$GNMX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aevi Genomic Medicine, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aevi Genomic Medicine, LLC. Get notifications about new insider transactions in Aevi Genomic Medicine, LLC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 08 2015 | MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Chief Scientific Of ... | Buy | P | 6.50 | 15,384 | 99,996 | 39,774 | 24.4 K to 39.8 K (+63.08 %) |
Oct 08 2015 | MDGN | MEDGENICS, INC. | GRANO JOSEPH J JR | Director | Buy | P | 6.50 | 15,384 | 99,996 | 15,384 | 0 to 15.4 K |
Sep 23 2015 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Option Exercise | X | 4.10 | 230,357 | 944,464 | 0 | |
Sep 23 2015 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Sell | S | 9.96 | 94,825 | 944,457 | 1,781,003 | 1.9 M to 1.8 M (-5.06 %) |
Sep 23 2015 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Buy | X | 4.10 | 230,357 | 944,464 | 1,875,828 | 1.6 M to 1.9 M (+14.00 %) |
Jul 23 2015 | MDGN | MEDGENICS, INC. | Duncan Barbara Gayle | Director | Option Exercise | A | 8.09 | 20,000 | 161,800 | 20,000 | |
Mar 23 2015 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 8.45 | 50,000 | 422,500 | 407,000 | 357 K to 407 K (+14.01 %) |
Mar 23 2015 | MDGN | MEDGENICS, INC. | BAUER EUGENE A | Director | Sell | S | 8.45 | 50,000 | 422,500 | 145,874 | 195.9 K to 145.9 K (-25.53 %) |
Feb 23 2015 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 7.55 | 50,000 | 377,500 | 357,000 | 307 K to 357 K (+16.29 %) |
Feb 23 2015 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 7.38 | 100,000 | 738,000 | 307,000 | 207 K to 307 K (+48.31 %) |
Feb 20 2015 | MDGN | MEDGENICS, INC. | GRANO JOSEPH J JR | Director | Option Exercise | A | 7.01 | 20,000 | 140,200 | 20,000 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | Leaman John Harold | Chief Financial Off ... | Option Exercise | A | 7.01 | 140,000 | 981,400 | 140,000 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | GANTZ WILBUR H | Director | Option Exercise | A | 7.01 | 20,000 | 140,200 | 20,000 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Option Exercise | A | 7.01 | 20,000 | 140,200 | 20,000 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | COLA MICHAEL F | President and CEO | Option Exercise | A | 7.01 | 292,087 | 2,047,530 | 292,087 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Option Exercise | A | 7.01 | 20,000 | 140,200 | 20,000 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | CLEMOW ALASTAIR J | Director | Option Exercise | A | 7.01 | 20,000 | 140,200 | 20,000 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Option Exercise | A | 7.01 | 20,000 | 140,200 | 20,000 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Chief Scientific Of ... | Option Exercise | A | 7.01 | 200,000 | 1,402,000 | 200,000 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | BAUER EUGENE A | Director | Option Exercise | A | 7.01 | 20,000 | 140,200 | 20,000 | |
Feb 20 2015 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | A | 7.01 | 80,000 | 560,800 | 80,000 | |
Dec 02 2014 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Buy | P | 4.10 | 2,439 | 10,000 | 96,274 | 93.8 K to 96.3 K (+2.60 %) |
Dec 02 2014 | MDGN | MEDGENICS, INC. | GRANO JOSEPH J JR | Director | Buy | P | 4.10 | 48,780 | 199,998 | 55,780 | 7 K to 55.8 K (+696.86 %) |
Dec 02 2014 | MDGN | MEDGENICS, INC. | GANTZ WILBUR H | Director | Buy | P | 4.10 | 24,390 | 99,999 | 31,390 | 7 K to 31.4 K (+348.43 %) |
Dec 02 2014 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 4.10 | 365,854 | 1,500,001 | 365,854 | 0 to 365.9 K |
Dec 02 2014 | MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Global Head of R&D | Buy | P | 4.10 | 24,390 | 99,999 | 24,390 | 0 to 24.4 K |
Dec 02 2014 | MDGN | MEDGENICS, INC. | CLEMOW ALASTAIR J T | Director | Buy | P | 4.10 | 12,195 | 50,000 | 37,695 | 25.5 K to 37.7 K (+47.82 %) |
Dec 02 2014 | MDGN | MEDGENICS, INC. | Applebaum Scott | Chief Legal Officer | Buy | P | 4.10 | 6,098 | 25,002 | 6,098 | 0 to 6.1 K |
Dec 02 2014 | MDGN | MEDGENICS, INC. | COLA MICHAEL F | President and CEO | Buy | P | 4.10 | 60,976 | 250,002 | 60,976 | 0 to 61 K |
Sep 10 2014 | MDGN | MEDGENICS, INC. | Applebaum Scott | Chief Legal Officer | Option Exercise | A | 6.04 | 450,000 | 2,718,000 | 450,000 | |
May 13 2014 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 6.91 | 60,000 | 414,300 | 179,000 | 119 K to 179 K (+50.42 %) |
Jun 16 2014 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 7.96 | 28,000 | 222,936 | 207,000 | 179 K to 207 K (+15.64 %) |
Apr 18 2014 | MDGN | MEDGENICS, INC. | Leaman John Harold | Chief Financial Off ... | Option Exercise | A | 6.45 | 10,314 | 66,525 | 10,314 | |
Apr 18 2014 | MDGN | MEDGENICS, INC. | COLA MICHAEL F | President and CEO | Option Exercise | A | 6.45 | 17,327 | 111,759 | 17,327 | |
Apr 18 2014 | MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Global Head of R&D | Option Exercise | A | 6.45 | 13,532 | 87,281 | 13,532 | |
Apr 18 2014 | MDGN | MEDGENICS, INC. | Bellin Phyllis K. | See Remarks | Option Exercise | A | 6.45 | 40,000 | 258,000 | 40,000 | |
Feb 14 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Option Exercise | M | 3.14 | 11,168 | 35,068 | 34,632 | |
Feb 14 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Sell | S | 9.00 | 11,168 | 100,512 | 40,562 | 51.7 K to 40.6 K (-21.59 %) |
Feb 14 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Buy | M | 3.14 | 11,168 | 35,068 | 51,730 | 40.6 K to 51.7 K (+27.53 %) |
Feb 06 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Option Exercise | M | 3.14 | 3,200 | 10,048 | 45,800 | |
Feb 06 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Option Exercise | M | 2.49 | 16,800 | 41,832 | 92,006 | |
Feb 06 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Sell | S | 8.00 | 20,000 | 160,000 | 40,562 | 60.6 K to 40.6 K (-33.02 %) |
Feb 06 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Buy | M | 3.14 | 3,200 | 10,048 | 60,562 | 57.4 K to 60.6 K (+5.58 %) |
Feb 06 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Buy | M | 2.49 | 16,800 | 41,832 | 57,362 | 40.6 K to 57.4 K (+41.42 %) |
Jan 31 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Option Exercise | M | 3.14 | 24,500 | 76,930 | 49,000 | |
Jan 31 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Option Exercise | M | 3.14 | 500 | 1,570 | 73,500 | |
Jan 31 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Sell | S | 7.50 | 24,500 | 183,750 | 40,562 | 65.1 K to 40.6 K (-37.66 %) |
Jan 31 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Buy | M | 3.14 | 24,500 | 76,930 | 65,062 | 40.6 K to 65.1 K (+60.40 %) |
Jan 31 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Sell | S | 7.50 | 500 | 3,750 | 40,562 | 41.1 K to 40.6 K (-1.22 %) |
Jan 31 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Buy | M | 3.14 | 500 | 1,570 | 41,062 | 40.6 K to 41.1 K (+1.23 %) |
Jan 10 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Option Exercise | M | 3.14 | 6,000 | 18,840 | 74,000 | |
Jan 10 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Option Exercise | M | 2.49 | 28,466 | 70,880 | 108,806 | |
Jan 10 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Option Exercise | M | 2.49 | 45,534 | 113,380 | 137,272 | |
Jan 10 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Sell | S | 6.69 | 34,466 | 230,578 | 40,562 | 75 K to 40.6 K (-45.94 %) |
Jan 10 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Buy | M | 3.14 | 6,000 | 18,840 | 75,028 | 69 K to 75 K (+8.69 %) |
Jan 10 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Buy | M | 2.49 | 28,466 | 70,880 | 69,028 | 40.6 K to 69 K (+70.18 %) |
Jan 10 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Sell | S | 6.54 | 45,534 | 297,792 | 40,562 | 86.1 K to 40.6 K (-52.89 %) |
Jan 10 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Buy | M | 2.49 | 45,534 | 113,380 | 86,096 | 40.6 K to 86.1 K (+112.26 %) |
Jan 06 2014 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Option Exercise | A | 6.50 | 15,000 | 97,500 | 15,000 | |
Jan 06 2014 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Grant | A | 0.00 | 7,000 | 0 | 21,000 | 14 K to 21 K (+50.00 %) |
Jan 06 2014 | MDGN | MEDGENICS, INC. | CLEMOW ALASTAIR J T | Director | Option Exercise | A | 6.50 | 15,000 | 97,500 | 15,000 | |
Jan 06 2014 | MDGN | MEDGENICS, INC. | CLEMOW ALASTAIR J T | Director | Grant | A | 0.00 | 7,000 | 0 | 25,500 | 18.5 K to 25.5 K (+37.84 %) |
Jan 06 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Option Exercise | A | 6.50 | 15,000 | 97,500 | 15,000 | |
Jan 06 2014 | MDGN | MEDGENICS, INC. | Pearlman Andrew | Director | Grant | A | 0.00 | 7,000 | 0 | 40,562 | 33.6 K to 40.6 K (+20.86 %) |
Jan 06 2014 | MDGN | MEDGENICS, INC. | GANTZ WILBUR H | Director | Option Exercise | A | 6.50 | 15,000 | 97,500 | 15,000 | |
Jan 06 2014 | MDGN | MEDGENICS, INC. | GANTZ WILBUR H | Director | Grant | A | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
Jan 06 2014 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | A | 6.50 | 15,000 | 97,500 | 15,000 | |
Jan 06 2014 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Grant | A | 0.00 | 7,000 | 0 | 119,000 | 112 K to 119 K (+6.25 %) |
Jan 06 2014 | MDGN | MEDGENICS, INC. | GRANO JOSEPH J JR | Director | Option Exercise | A | 6.50 | 15,000 | 97,500 | 15,000 | |
Jan 06 2014 | MDGN | MEDGENICS, INC. | GRANO JOSEPH J JR | Director | Grant | A | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
Jan 06 2014 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Option Exercise | A | 6.50 | 15,000 | 97,500 | 15,000 | |
Jan 06 2014 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Grant | A | 0.00 | 7,000 | 0 | 93,835 | 86.8 K to 93.8 K (+8.06 %) |
Jan 06 2014 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Option Exercise | A | 6.50 | 15,000 | 97,500 | 15,000 | |
Jan 06 2014 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Grant | A | 0.00 | 7,000 | 0 | 119,804 | 112.8 K to 119.8 K (+6.21 %) |
Dec 18 2013 | MDGN | MEDGENICS, INC. | CLEMOW ALASTAIR J T | Director | Buy | P | 5.78 | 4,500 | 26,005 | 18,500 | 14 K to 18.5 K (+32.14 %) |
Dec 16 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 5.37 | 20,000 | 107,422 | 112,000 | 92 K to 112 K (+21.74 %) |
Dec 09 2013 | MDGN | MEDGENICS, INC. | DELLIO CLARENCE L | Chief Operating Off ... | Sell | S | 6.50 | 2,000 | 13,000 | 2,500 | 4.5 K to 2.5 K (-44.44 %) |
Dec 04 2013 | MDGN | MEDGENICS, INC. | BAUER EUGENE A | Director | Sell | S | 6.35 | 5,000 | 31,750 | 195,874 | 200.9 K to 195.9 K (-2.49 %) |
Dec 04 2013 | MDGN | MEDGENICS, INC. | BAUER EUGENE A | Director | Sell | S | 6.28 | 15,000 | 94,161 | 200,874 | 215.9 K to 200.9 K (-6.95 %) |
Dec 03 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 6.59 | 20,000 | 131,780 | 92,000 | 72 K to 92 K (+27.78 %) |
Nov 13 2013 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Option Exercise | A | 6.70 | 50,000 | 335,000 | 50,000 | |
Nov 13 2013 | MDGN | MEDGENICS, INC. | BAUER EUGENE A | Director | Option Exercise | A | 6.70 | 50,000 | 335,000 | 50,000 | |
Nov 13 2013 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Option Exercise | A | 6.70 | 50,000 | 335,000 | 50,000 | |
Nov 13 2013 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Option Exercise | A | 6.70 | 50,000 | 335,000 | 50,000 | |
Nov 13 2013 | MDGN | MEDGENICS, INC. | CLEMOW ALASTAIR J T | Director | Option Exercise | A | 6.70 | 50,000 | 335,000 | 50,000 | |
Nov 12 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 6.80 | 25,000 | 170,123 | 72,000 | 47 K to 72 K (+53.19 %) |
Oct 18 2013 | MDGN | MEDGENICS, INC. | GANTZ WILBUR H | Director | Option Exercise | A | 6.29 | 300,000 | 1,887,000 | 300,000 | |
Oct 01 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | G | 5.22 | 200,000 | 1,044,000 | 200,000 | |
Oct 01 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | G | 5.22 | 200,000 | 1,044,000 | 0 | |
Oct 01 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | G | 10.80 | 450,000 | 4,860,000 | 450,000 | |
Oct 01 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | G | 10.80 | 450,000 | 4,860,000 | 0 | |
Sep 24 2013 | MDGN | MEDGENICS, INC. | Bellin Phyllis K. | See Remarks | Option Exercise | A | 7.02 | 25,000 | 175,500 | 25,000 | |
Sep 20 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 6.50 | 20,000 | 129,996 | 47,000 | 27 K to 47 K (+74.07 %) |
Sep 19 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Buy | P | 5.57 | 20,000 | 111,478 | 27,000 | 7 K to 27 K (+285.71 %) |
Sep 17 2013 | MDGN | MEDGENICS, INC. | COLA MICHAEL F | President and CEO | Option Exercise | A | 4.22 | 1,500,000 | 6,330,000 | 1,500,000 | |
Sep 17 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | A | 5.22 | 400,000 | 2,088,000 | 400,000 | |
Sep 17 2013 | MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Global Head of R&D | Option Exercise | A | 4.22 | 900,000 | 3,798,000 | 900,000 | |
Sep 17 2013 | MDGN | MEDGENICS, INC. | Leaman John Harold | Chief Financial Off ... | Option Exercise | A | 4.22 | 800,000 | 3,376,000 | 800,000 | |
Jun 05 2013 | MDGN | MEDGENICS, INC. | DELLIO CLARENCE L | Chief Operating Off ... | Buy | P | 4.14 | 712 | 2,948 | 4,500 | 3.8 K to 4.5 K (+18.80 %) |
Jun 05 2013 | MDGN | MEDGENICS, INC. | DELLIO CLARENCE L | Chief Operating Off ... | Buy | P | 4.14 | 288 | 1,192 | 3,788 | 3.5 K to 3.8 K (+8.23 %) |
Apr 16 2013 | MDGN | MEDGENICS, INC. | GRANO JOSEPH J JR | Director | Option Exercise | A | 4.99 | 300,000 | 1,497,000 | 300,000 | |
Mar 22 2013 | MDGN | MEDGENICS, INC. | DELLIO CLARENCE L | Chief Operating Off ... | Option Exercise | M | 3.64 | 3,500 | 12,740 | 32,200 | |
Mar 22 2013 | MDGN | MEDGENICS, INC. | DELLIO CLARENCE L | Chief Operating Off ... | Buy | M | 3.64 | 3,500 | 12,740 | 3,500 | 0 to 3.5 K |
Jan 14 2013 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Option Exercise | A | 7.25 | 15,000 | 108,750 | 15,000 | |
Jan 14 2013 | MDGN | MEDGENICS, INC. | BLECH ISAAC | Director | Grant | A | 0.00 | 7,000 | 0 | 14,000 | 7 K to 14 K (+100.00 %) |
Jan 10 2013 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Option Exercise | A | 7.25 | 15,000 | 108,750 | 15,000 | |
Jan 10 2013 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Grant | A | 0.00 | 7,000 | 0 | 86,835 | 79.8 K to 86.8 K (+8.77 %) |
Jan 10 2013 | MDGN | MEDGENICS, INC. | CLEMOW ALASTAIR J T | Director | Option Exercise | A | 7.25 | 15,000 | 108,750 | 15,000 | |
Jan 10 2013 | MDGN | MEDGENICS, INC. | CLEMOW ALASTAIR J T | Director | Grant | A | 0.00 | 7,000 | 0 | 14,000 | 7 K to 14 K (+100.00 %) |
Jan 10 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | A | 7.25 | 15,000 | 108,750 | 15,000 | |
Jan 10 2013 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Grant | A | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
Jan 10 2013 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Option Exercise | A | 7.25 | 15,000 | 108,750 | 15,000 | |
Jan 10 2013 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Grant | A | 0.00 | 7,000 | 0 | 112,804 | 105.8 K to 112.8 K (+6.62 %) |
Sep 27 2012 | MDGN | MEDGENICS, INC. | Bellomo Stephen | See Remarks | Sell | S | 10.99 | 350 | 3,847 | 0 | 350 to 0 (-100.00 %) |
Sep 27 2012 | MDGN | MEDGENICS, INC. | Bellin Phyllis K. | See Remarks | Sell | S | 10.90 | 400 | 4,360 | 10,664 | 11.1 K to 10.7 K (-3.62 %) |
Sep 27 2012 | MDGN | MEDGENICS, INC. | Bellin Phyllis K. | See Remarks | Sell | S | 10.92 | 5,082 | 55,495 | 11,064 | 16.1 K to 11.1 K (-31.48 %) |
Sep 24 2012 | MDGN | MEDGENICS, INC. | Pearlman Andrew | President and CEO | Option Exercise | G | 2.49 | 6,750 | 16,808 | 27,050 | |
Sep 19 2012 | MDGN | MEDGENICS, INC. | Pearlman Andrew | President and CEO | Sell | S | 10.24 | 5,000 | 51,200 | 33,562 | 38.6 K to 33.6 K (-12.97 %) |
Sep 19 2012 | MDGN | MEDGENICS, INC. | Pearlman Andrew | President and CEO | Sell | S | 10.29 | 6,000 | 61,740 | 38,562 | 44.6 K to 38.6 K (-13.46 %) |
Sep 18 2012 | MDGN | MEDGENICS, INC. | DELLIO CLARENCE L | Chief Operating Off ... | Sell | S | 10.74 | 3,007 | 32,295 | 0 | 3 K to 0 (-100.00 %) |
Sep 13 2012 | MDGN | MEDGENICS, INC. | Bellin Phyllis K. | See Remarks | Option Exercise | M | 7.35 | 13,964 | 102,635 | 0 | |
Sep 13 2012 | MDGN | MEDGENICS, INC. | Bellin Phyllis K. | See Remarks | Payment of Exercise | F | 12.10 | 8,482 | 102,632 | 16,146 | 24.6 K to 16.1 K (-34.44 %) |
Sep 13 2012 | MDGN | MEDGENICS, INC. | Bellin Phyllis K. | See Remarks | Buy | M | 7.35 | 13,964 | 102,635 | 24,628 | 10.7 K to 24.6 K (+130.95 %) |
Sep 17 2012 | MDGN | MEDGENICS, INC. | Pearlman Andrew | President and CEO | Sell | S | 10.73 | 4,000 | 42,920 | 44,562 | 48.6 K to 44.6 K (-8.24 %) |
Sep 17 2012 | MDGN | MEDGENICS, INC. | Pearlman Andrew | President and CEO | Sell | S | 10.66 | 19,623 | 209,181 | 48,562 | 68.2 K to 48.6 K (-28.78 %) |
Sep 13 2012 | MDGN | MEDGENICS, INC. | Pearlman Andrew | President and CEO | Option Exercise | M | 7.35 | 91,403 | 671,812 | 0 | |
Sep 13 2012 | MDGN | MEDGENICS, INC. | Pearlman Andrew | President and CEO | Payment of Exercise | F | 11.83 | 56,780 | 671,707 | 68,185 | 125 K to 68.2 K (-45.44 %) |
Sep 13 2012 | MDGN | MEDGENICS, INC. | Pearlman Andrew | President and CEO | Buy | M | 7.35 | 91,403 | 671,812 | 124,965 | 33.6 K to 125 K (+272.34 %) |
Sep 13 2012 | MDGN | MEDGENICS, INC. | DELLIO CLARENCE L | Chief Operating Off ... | Option Exercise | M | 3.64 | 4,300 | 15,652 | 35,700 | |
Sep 13 2012 | MDGN | MEDGENICS, INC. | DELLIO CLARENCE L | Chief Operating Off ... | Payment of Exercise | F | 12.10 | 1,293 | 15,645 | 3,007 | 4.3 K to 3 K (-30.07 %) |
Sep 13 2012 | MDGN | MEDGENICS, INC. | DELLIO CLARENCE L | Chief Operating Off ... | Buy | M | 3.64 | 4,300 | 15,652 | 4,300 | 0 to 4.3 K |
Sep 12 2012 | MDGN | MEDGENICS, INC. | Bellomo Stephen | See Remarks | Option Exercise | M | 7.35 | 891 | 6,549 | 0 | |
Sep 12 2012 | MDGN | MEDGENICS, INC. | Bellomo Stephen | See Remarks | Payment of Exercise | F | 12.10 | 541 | 6,546 | 350 | 891 to 350 (-60.72 %) |
Sep 12 2012 | MDGN | MEDGENICS, INC. | Bellomo Stephen | See Remarks | Buy | M | 7.35 | 891 | 6,549 | 891 | 0 to 891 |
Sep 04 2012 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Sell | S | 13.03 | 700 | 9,121 | 105,804 | 106.5 K to 105.8 K (-0.66 %) |
Aug 28 2012 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Sell | S | 12.50 | 10,935 | 136,688 | 79,835 | 90.8 K to 79.8 K (-12.05 %) |
Aug 24 2012 | MDGN | MEDGENICS, INC. | BAUER EUGENE A | Director | Option Exercise | M | 7.35 | 82,327 | 605,103 | 0 | |
Aug 24 2012 | MDGN | MEDGENICS, INC. | BAUER EUGENE A | Director | Payment of Exercise | F | 10.64 | 56,871 | 605,107 | 215,874 | 272.7 K to 215.9 K (-20.85 %) |
Aug 24 2012 | MDGN | MEDGENICS, INC. | BAUER EUGENE A | Director | Buy | M | 7.35 | 82,327 | 605,103 | 272,745 | 190.4 K to 272.7 K (+43.23 %) |
Aug 21 2012 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Option Exercise | M | 7.35 | 33,052 | 242,932 | 0 | |
Aug 21 2012 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Payment of Exercise | F | 10.98 | 22,117 | 242,845 | 90,770 | 112.9 K to 90.8 K (-19.59 %) |
Aug 21 2012 | MDGN | MEDGENICS, INC. | MCMURRAY STEPHEN D | Director | Buy | M | 7.35 | 33,052 | 242,932 | 112,887 | 79.8 K to 112.9 K (+41.40 %) |
Aug 20 2012 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Option Exercise | M | 7.35 | 38,803 | 285,202 | 0 | |
Aug 20 2012 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Option Exercise | M | 7.35 | 10,000 | 73,500 | 38,803 | |
Aug 20 2012 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Buy | M | 7.35 | 38,803 | 285,202 | 106,504 | 67.7 K to 106.5 K (+57.32 %) |
Aug 20 2012 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Buy | M | 7.35 | 10,000 | 73,500 | 67,701 | 57.7 K to 67.7 K (+17.33 %) |
Jul 19 2012 | MDGN | MEDGENICS, INC. | BARER SOL J | Director | Option Exercise | A | 10.80 | 900,000 | 9,720,000 | 900,000 | |
Jul 18 2012 | MDGN | MEDGENICS, INC. | Garovoy Marvin | Chief Medical Offic ... | Option Exercise | A | 14.50 | 20,000 | 290,000 | 20,000 | |
Jun 25 2012 | MDGN | MEDGENICS, INC. | Pearlman Andrew | President and CEO | Option Exercise | G | 2.49 | 16,200 | 40,338 | 33,800 | |
Jun 22 2012 | MDGN | MEDGENICS, INC. | KANTER JOEL S | Director | Option Exercise | M | 6.55 | 4,286 | 28,073 | 8,571 |